174 related articles for article (PubMed ID: 9676562)
21. [The diagnosis of Cushing's syndrome. Results of diagnostic assessment of 20 patients with Cushing's syndrome of variable etiology (1979-1989)].
Caduff F; Staub JJ; Nordmann A; Radü EW; Landolt H
Schweiz Med Wochenschr; 1991 Jan; 121(1-2):10-20. PubMed ID: 1990418
[TBL] [Abstract][Full Text] [Related]
22. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
Tang TJ; Liu YP; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
24. A follow-up of the "low dose suppressible" hypercortisolism.
Kreze A; Velemínský J; Spirová E
Endocrinol Exp; 1983 Jun; 17(2):119-23. PubMed ID: 6603966
[TBL] [Abstract][Full Text] [Related]
25. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay.
Deutschbein T; Broecker-Preuss M; Flitsch J; Jaeger A; Althoff R; Walz MK; Mann K; Petersenn S
Eur J Endocrinol; 2012 Apr; 166(4):613-8. PubMed ID: 22214924
[TBL] [Abstract][Full Text] [Related]
26. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
27. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
28. The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome.
Reimondo G; Bovio S; Allasino B; De Francia S; Zaggia B; Micossi I; Termine A; De Martino F; Paccotti P; Di Carlo F; Angeli A; Terzolo M
Eur J Endocrinol; 2008 Nov; 159(5):569-76. PubMed ID: 18713844
[TBL] [Abstract][Full Text] [Related]
29. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
30. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
[TBL] [Abstract][Full Text] [Related]
31. A FOUR-DAY CORTICOTROPHIN-SUPPRESSION TEST. STUDIES IN CUSHING'S SYNDROME AND IN NON CUSHING SUBJECTS WITH RELATED SYMPTOMS.
ERNEST I
Acta Endocrinol (Copenh); 1965 Jan; 48():147-62. PubMed ID: 14254767
[No Abstract] [Full Text] [Related]
32. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
Friedman TC
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
[TBL] [Abstract][Full Text] [Related]
33. Cushing's disease.
Bertagna X; Guignat L; Groussin L; Bertherat J
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):607-23. PubMed ID: 19945026
[TBL] [Abstract][Full Text] [Related]
34. Cushing's syndrome.
Shibli-Rahhal A; Van Beek M; Schlechte JA
Clin Dermatol; 2006; 24(4):260-5. PubMed ID: 16828407
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of abnormal adrenocortical function in human immunodeficiency virus infection by low-dose cosyntropin test.
González-González JG; de la Garza-Hernández NE; Garza-Morán RA; Rivera-Morales IM; Montes-Villarreal J; Valenzuela-Rendón J; Villarreal-Pérez JZ
Int J STD AIDS; 2001 Dec; 12(12):804-10. PubMed ID: 11779371
[TBL] [Abstract][Full Text] [Related]
37. Dynamic evaluation of adrenal hypofunction.
Nieman LK
J Endocrinol Invest; 2003; 26(7 Suppl):74-82. PubMed ID: 14604069
[TBL] [Abstract][Full Text] [Related]
38. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease.
Esfahanian F; Kazemi R
Acta Med Iran; 2010; 48(4):222-5. PubMed ID: 21279933
[TBL] [Abstract][Full Text] [Related]
39. APPRAISAL OF ADRENOCORTICAL HYPERFUNCTION: PATIENTS WITH CUSHING'S SYNDROME OR "NON-ENDOCRINE" TUMORS.
BROOKS RV; DUPRE J; GOGATE AN; MILLS IH; PRUNTY FT
J Clin Endocrinol Metab; 1963 Aug; 23():725-36. PubMed ID: 14059549
[No Abstract] [Full Text] [Related]
40. Evaluation of the integrated 3-hour plasma cortisol concentration as a test for Cushing's syndrome.
Desai RK; Jialal I; Naidoo C; Omar MA; Joubert SM
S Afr Med J; 1987 Feb; 71(3):156-7. PubMed ID: 3810361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
